@ShahidNShah
The MedTech Trends to Watch in 2023
Bernard Ross, CEO of Sky Medical Technology, highlights what he expects from the world of medtech and healthcare going into 2023. The global epidemic put the NHS under unprecedented stress at a time when it was already working tirelessly to address the chronic problems brought on by an ageing population. At the height of the pandemic, doctors and nurses were redistributed around the system, diminishing capacity elsewhere, in order to handle the grave threat to people's lives. While lockdowns were in effect, outpatient clinics were closed and remote diagnostics were increased. We are currently dealing with the effects. People all around the country are coping with long-term physical and mental health concerns, the NHS is dealing with a growing backlog of elective surgery that has reached a record level, and the closing of outpatient clinics meant that new clinical studies were halted or postponed.
Continue reading at med-technews.com
Make faster decisions with community advice
- AI is fast addressing data requirements and advancing interoperability, says one expert
- How the 2022 funding environment affected digital health startups
- Alembic Pharma gets USFDA nod for generic drug to treat breast cancer
- Digital Health Tools Need a New Benchmark (and Evidence)
- Healthcare Private Equity in 2022: Challenges and Opportunities for Digital Health Investment
Next Article
-
Alembic Pharma gets USFDA nod for generic drug to treat breast cancer
The approved injectable is therapeutically equal to AstraZeneca Pharmaceuticals LP's Faslodex Injection, which is a reference listed drug product (RLD). According to a statement from the firm, the US …
Posted Dec 27, 2022 Breast Cancer